This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, appropriate agents to improve outcomes for patients with stage IIB-IV resectable melanoma.
Improving Outcomes in Patients with RVO: Tailoring Treatment
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Patient-Centric Approaches to Managing Migraines in the Female Patient
Expert Answers to Common Questions on Response Matters: Transforming the Standard of Care in CML by Mastering Response-Guided Treatment
Expert Answers to Common Questions for Tailoring ADC Therapies Across the HER2 Spectrum in Metastatic Breast Cancer
HER2 & PD-L1: Exploring Clinical Characteristics of G/GEJ Cancers in Relation to Biomarker Positivity
Claudin18.2: An Emerging Biomarker and Its Significance as a Therapeutic Target in G/GEJ Cancers
What Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?
What Is the Current Standard for First-Line Treatment of Metastatic HER2-Positive G/GEJ Cancers?
What Is the Evidence Supporting CLDN18.2 Targeting in Frontline Management of G/GEJ Cancers
Incorporating Data Into Practice: Late-Breaking Highlights on G/GEJ Cancers From the 2024 GI Congress
Systemic Gout Uncovered: Primary Care Perspectives and Solutions
Putting Data into Clinical Practice
It’s All About Patient Identification
New TAVR Data – New TAVR Talk Track
Challenging TAVR Cases
What Are the Data Behind ATT?
Which Amyloid-Targeting Therapy is Best?
What’s the Best Way to Identify Mild Cognitive Impairment and Early Alzheimer’s Disease?
What is the Role of APOE4 Testing in Alzheimer’s Disease?
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
Exercise: Learn To Love (Or At Least Like) It
NASACast Video